Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Alnylam Pharmace. buy Chardan Capital

Alnylam Pharmace.
Start price
€179.35
31.07.26 / 50%
Target price
€369.24
31.07.27
Performance (%)
5.52%
Price
€189.25
21:40
Summary
This prediction is currently active. The BUY prediction by Chardan_Capital shows slight gains of 5.52%. This prediction currently runs until 31.07.27. The prediction end date can be changed by Chardan_Capital at any time. Chardan_Capital has 50% into this prediction

Alnylam Pharmaceuticals, Inc. (ALNY) is a biopharmaceutical company focused on the development of RNA interference (RNAi) therapeutics. Its lead drug, ONPATTRO®, is approved by the U.S. FDA for the treatment of adults with polyneuropathy of hereditary transthyretin-mediated (hATTR) amyloidosis. The company is also developing additional RNAi therapeutic candidates for the treatment of a range of diseases, including cancer, cardiovascular disease, and viral infections. With a market capitalization of over $15 billion, Alnylam is one of the largest biotech companies in the world.

AI-generated
Performance without dividends (%)
Name 1w
Alnylam Pharmace. 5.52%
iShares Core DAX® 2,33 %
iShares Nasdaq 100 1,37 %
iShares Nikkei 225® 2,44 %
iShares S&P 500 1,26 %

Comments by Chardan_Capital for this prediction

In the thread Alnylam Pharmace. diskutieren
Prediction Buy
Perf. (%) 5.52%
Target price 369.240
Change
Ends at 31.07.27

Alnylam Pharmaceuticals (ALNY) had its "buy" rating reaffirmed by Chardan Capital. They now have a $425.00 price target on the stock.
Ratings data for ALNY provided by MarketBeat

Chardan Capital 
0
Report Share
31.07.26

Stopped prediction by Chardan_Capital for Alnylam Pharmace.

buy
Alnylam Pharmace.

Start price
Target price
Perf. (%)
€281.10
25.03.26
€366.18
25.03.27
-32.57%
21:40

Chardan Capital 
25.03.26 50%
buy
Alnylam Pharmace.

Start price
Target price
Perf. (%)
€229.30
02.05.25
€287.76
02.05.26
10.95%
03.05.26

Chardan Capital 
02.05.25 50%
buy
Alnylam Pharmace.

Start price
Target price
Perf. (%)
€236.90
26.02.25
€286.08
26.02.26
18.66%
27.02.26

Chardan Capital 
26.02.25 50%
buy
Alnylam Pharmace.

Start price
Target price
Perf. (%)
€260.20
11.10.24
€274.17
11.10.25
52.23%
12.10.25

Chardan Capital 
11.10.24 50%
buy
Alnylam Pharmace.

Start price
Target price
Perf. (%)
€139.00
16.02.24
€209.30
16.02.25
77.27%
17.02.25

Chardan Capital 
16.02.24 50%
buy
Alnylam Pharmace.

Start price
Target price
Perf. (%)
€168.60
08.08.23
€228.30
08.08.24
46.56%
09.08.24

Chardan Capital 
08.08.23 50%